Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: Preventive effect of indomethacin

European Journal of Neuroscience

Volumn 31, Issue 2, 2010, Pages 315-326

  Gonçalves, Joana ^a,c   Baptista, Sofia ^a,b   Martins, Tânia ^a   Milhazes, Nuno ^c   Borges, Fernanda ^d   Ribeiro, Carlos F ^a   Malva, João O ^a,b   Silva, Ana P ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c Institute of Health Sciences North   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Astrocytes; Hippocampus; Methamphetamine; Microglia; Neurons; TNF

Indexed keywords

BETA TUBULIN; CD11B ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; INDOMETACIN; METHAMPHETAMINE; STRUCTURAL PROTEIN; SYNAPTOPHYSIN; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENCEPHALITIS; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MICROGLIA; MOUSE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD11B; CENTRAL NERVOUS SYSTEM STIMULANTS; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; INDOMETHACIN; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; NEUROGLIA; NEURONS; QA-SNARE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SYNAPTOPHYSIN; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TUMOR NECROSIS FACTOR-ALPHA;

EID: 74549150090     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2009.07059.x     Document Type: Article

References (74)

1. Armbrust, E. Röhl, C. (2008) Time- and activation-dependency of the protective effect of microglia on astrocytes exposed to peroxide-induced oxidative stress. Toxicol. In Vitro, 22, 1399 1404.
2. Asanuma, M., Tsuji, T., Miyazaki, I., Miyoshi, K. Ogawa, N. (2003) Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug. Neurosci. Lett., 352, 13 16.
3. Belcher, A.M., O'Dell, S.J. Marshall, J.F. (2005) Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology, 30, 2026 2034.
4. Bernardino, L., Xapelli, S., Silva, A.P., Jakobsen, B., Poulsen, F.R., Oliveira, C.R., Vezzani, A., Malva, J.O. Zimmer, J. (2005) Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J. Neurosci., 25, 6734 6744.
5. Bu, L. Lephart, E.D. (2005) Soy isoflavones modulate the expression of BAD and neuron-specific beta III tubulin in male rat brain. Neurosci. Lett., 385, 153 157.
6. Cadet, J.L., Krasnova, I.N., Jayanthi, S. Lyles, J. (2007) Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox. Res., 11, 183 202.
7. Calhoun, M.E., Jucker, M., Martin, L.J., Thinakaran, G., Price, D.L. Mouton, P.R. (1996) Comparative evaluation of synaptophysin-based methods for quantification of synapses. J. Neurocytol., 25, 821 828.
8. Castner, S.A., Vosler, P.S. Goldman-Rakic, P.S. (2005) Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex. Biol. Psychiatry, 57, 743 751.
9. Centonze, D., Muzio, L., Rossi, S., Cavasinni, F., De Chiara, V., Bergami, A., Musella, A., D'Amelio, M., Cavallucci, V., Martorana, A., Bergamaschi, A., Cencioni, M.T., Diamantini, A., Butti, E., Comi, G., Bernardi, G., Cecconi, F., Battistini, L., Furlan, R. Martino, G. (2009) Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J. Neurosci., 29, 3442 3452.
10. Clausen, B.H., Lambertsen, K.L., Babcock, A.A., Holm, T.H., Dagnaes-Hansen, F. Finsen, B. (2008) Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J. Neuroinflammation, 5, 46.
11. Eskes, C., Honegger, P., Juillerat-Jeanneret, L. Monnet-Tschudi, F. (2002) Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia, 37, 43 52.
12. Fantegrossi, W.E., Ciullo, J.R., Wakabayashi, K.T., De La Garza, R. II., Traynor, J.R. Woods, J.H. (2008) A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4- methylenedioxymethamphetamine in the mouse. Neuroscience, 151, 533 543.
13. Farooqui, A.A., Horrocks, L.A. Farooqui, T. (2007) Modulation of inflammation in brain: a matter of fat. J. Neurochem., 101, 577 599.
14. Figiel, I. (2008) Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain. Acta Neurobiol. Exp., 68, 526 534.
15. Gold, M.S., Kobeissy, F.H., Wang, K.K., Merlo, L.J., Bruijnzeel, A.W., Krasnova, I.N. Cadet, J.L. (2009) Methamphetamine- and Trauma-Induced Brain Injuries: comparative Cellular and Molecular Neurobiological Substrates. Biol. Psychiatry, 66, 118 127.
16. Gonçalves, J., Martins, T., Ferreira, R., Milhazes, N., Borges, F., Ribeiro, C.F., Malva, J.O., Macedo, T.R. Silva, A.P. (2008) Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain. Ann. N Y Acad. Sci., 1139, 103 111.
17. Gorlovoy, P., Larionov, S., Pham, T.T. Neumann, H. (2009) Accumulation of tau induced in neurites by microglial pro-inflammatory mediators. FASEB J., 23, 2502 2513.
18. Gould, E., Vail, N., Wagers, M. Gross, C.G. (2001) Adult-generated hippocampal and neocorticalneurons in macaques have a transient existence. Proc. Natl Acad. Sci. USA, 98, 10910 10917.
19. Gross, N.B. Marshall, J.F. (2009) Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression. Neuroscience, 21, 1114 1125.
20. Harry, G.J., d'Hellencourt, C.L., McPherson, C.A., Funk, J.A., Aoyama, M. Wine, R.N. (2008) Tumor necrosis factor p55 and p75 receptors are involved in chemical-induced apoptosis of dentate granule neurons. J. Neurochem., 106, 281 298.
21. Helme-Guizon, A., Davis, S., Israel, M., Lesbats, B., Mallet, J., Laroche, S. Hicks, A. (1998) Increase in syntaxin 1B and glutamate release in mossy fibre terminals following induction of LTP in the dentate gyrus: a candidate molecular mechanism underlying transsynaptic plasticity. Eur. J. Neurosci., 10, 2231 2237.
22. Herber, D.L., Maloney, J.L., Roth, L.M., Freeman, M.J., Morgan, D. Gordon, M.N. (2006) Diverse microglial responses after intrahippocampal administration of lipopolysaccharide. Glia, 53, 382 391.
23. Hua, Y., Wu, J., Keep, R.F., Nakamura, T., Hoff, J.T. Xi, G. (2006) Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery, 58, 542 550.
24. Iqbal, K., Liu, F., Gong, C.X., Alonso, A.D. Grundke-Iqbal, I. (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol., 118, 53 69.
25. Iravani, M.M., Leung, C.C., Sadeghian, M., Haddon, C.O., Rose, S. Jenner, P. (2005) The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Eur. J. Neurosci., 22, 317 330.
26. Johnson, G.V. Stoothoff, W.H. (2004) Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci., 117, 5721 5729.
27. Kinouchi, K., Brown, G., Pasternak, G. Donner, D.B. (1991) Identification and characterization of receptors for tumor necrosis factor-alpha in the brain. Biochem. Biophys. Res. Commun., 181, 1532 1538.
28. Kolesnick, R. Golde, D.W. (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell, 77, 325 328.
29. Krasnova, I.N. Cadet, J.L. (2009) Methamphetamine toxicity and messengers of death. Brain Res. Rev., 60, 370 407.
30. Kriz, J. Lalancette-Hébert, M. (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol., 117, 497 509.
31. Lai, Y.T., Tsai, Y.P., Cherng, C.G., Ke, J.J., Ho, M.C., Tsai, C.W. Yu, L. (2009) Lipopolysaccharide mitagates methamphetamine-induced striatal dopamine depletion via modulating local TNF-alpha and dopamine transporter expression. J. Neural Transm., 116, 405 415.
32. Lambertsen, K.L., Clausen, B.H., Babcock, A.A., Gregersen, R., Fenger, C., Nielsen, H.H., Haugaard, L.S., Wirenfeldt, M., Nielsen, M., Dagnaes-Hansen, F., Bluethmann, H., Faergeman, N.J., Meldgaard, M., Deierborg, T. Finsen, B. (2009) Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci., 29, 1319 1330.
33. LaVoie, M.J., Card, J.P. Hastings, T.G. (2004) Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp. Neurol., 187, 47 57.
34. Lehtimäki, K.A., Peltola, J., Koskikallio, E., Keränen, T. Honkaniemi, J. (2003) Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain Res. Mol. Brain Res., 110, 253 260.
35. Liu, Y.Y. Ju, G. (2001) Quantitative evaluation of synaptophysin-like immunoreactive nerve terminals or varicosities in anterior pituitary of normal and adrenalectomized rats. J. Neuroendocrinol., 13, 967 974.
36. Maccioni, R.B., Rojo, L.E., Fernández, J.A. Kuljis, R.O. (2009) The role of neuroimmunomodulation in Alzheimer's disease. Ann. N Y Acad. Sci., 1153, 240 246.
37. Mattson, M.P., Barger, S.W., Furukawa, K., Bruce, A.J., Wyss-Coray, T., Mark, R.J. Mucke, L. (1997) Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res. Brain Res. Rev., 23, 47 61.
38. McCann, U.D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brasic, J., Ye, W., Alexander, M., Dannals, R.F., Wong, D.F. Ricaurte, G.A. (2008) Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse, 62, 91 100.
39. McCoy, M.K. Tansey, M.G. (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflammation, 5, 45.
40. McGeer, P.L. McGeer, E.G. (2002) Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging, 22, 799 809.
41. Nakajima, A., Yamada, K., Nagai, T., Uchiyama, T., Miyamoto, Y., Mamiya, T., He, J., Nitta, A., Mizuno, M., Tran, M.H., Seto, A., Yoshimura, M., Kitaichi, K., Hasegawa, T., Saito, K., Yamada, Y., Seishima, M., Sekikawa, K., Kim, H.C. Nabeshima, T. (2004) Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. J. Neurosci., 24, 2212 2225. (Pubitemid 38314553)
42. Narita, M., Miyatake, M., Shibasaki, M., Tsuda, M., Koizumi, S., Narita, M., Yajima, Y., Inoue, K. Suzuki, T. (2005) Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization. J. Neurochem., 93, 1383 1392.
43. Narita, M., Suzuki, M., Kuzumaki, N., Miyatake, M. Suzuki, T. (2008) Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine. Ann. N Y Acad. Sci., 1141, 96 104.
44. O'Callaghan, J.P. Miller, D.B. (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther., 270, 741 751.
45. Olsson, T., Kelic, S., Edlund, C., Bakhiet, M., Höjeberg, B., van der Meide, P.H., Ljungdahl, A. Kristensson, K. (1994) Neuronal interferon-gamma immunoreactive molecule: bioactivities and purification. Eur. J. Immunol., 24, 308 314.
46. Parepally, J.M., Mandula, H. Smith, Q.R. (2006) Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin. Pharm. Res., 23, 873 881.
47. Pereira, F.C., Lourenço, E.S., Borges, F., Morgadinho, T., Ribeiro, C.F., Macedo, T.R. Ali, S.F. (2006) Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen. Synapse, 60, 185 193.
48. Piehl, F. Lidman, O. (2001) Neuroinflammation in the rat - CNS cells and their role in the regulation of immune reactions. Immunol. Rev., 184, 212 225.
49. Pubill, D., Canudas, A.M., Pallàs, M., Camins, A., Camarasa, J. Escubedo, E. (2003) Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity. Naunyn Schmiedebergs Arch. Pharmacol., 367, 490 499.
50. Quinton, M.S. Yamamoto, B.K. (2006) Causes and consequences of methamphetamine and MDMA toxicity. AAPS J., 8, E337 E347.
51. Rademacher, D.J., Kovacs, B., Shen, F., Napier, T.C. Meredith, G.E. (2006) The neural substrates of amphetamine conditioned place preference: implications for the formation of conditioned stimulus-reward associations. Eur. J. Neurosci., 24, 2089 2097.
52. Rosenzweig, H.L., Minami, M., Lessov, N.S., Coste, S.C., Stevens, S.L., Henshall, D.C., Meller, R., Simon, R.P. Stenzel-Poore, M.P. (2007) Endotoxin preconditioning protects against the cytotoxic effects of TNFa after stroke: a novel role for TNFa in LPS-ischemic tolerance. J. Cereb. Blood Flow Metab., 27, 1663 1674.
53. Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K.J., Suda, S., Suzuki, K., Kawai, M., Takebayashi, K., Yamamoto, S., Matsuzaki, H., Ueki, T., Mori, N., Gold, M.S. Cadet, J.L. (2008) Methamphetamine causes microglial activation in the brains of human abusers. J. Neurosci., 28, 5756 5761.
54. Seri, B., García-Verdugo, J.M., Collado-Morente, L., McEwen, B.S. Alvarez-Buylla, A. (2004) Cell types, lineage, and architecture of the germinal zone in the adult dentate gyrus. J. Comp. Neurol., 25, 359 378.
55. Simões, P.F., Silva, A.P., Pereira, F.C., Marques, E., Grade, S., Milhazes, N., Borges, F., Ribeiro, C.F. Macedo, T.R. (2007) Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience, 150, 433 441.
56. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J. Klenk, D.C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76 85.
57. Sriram, K. O'Callaghan, J.P. (2007) Divergent roles for tumor necrosis factor-alpha in the brain. J. Neuroimmune Pharmacol., 2, 140 153.
58. Sriram, K., Miller, D.B. O'Callaghan, J.P. (2006a) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J. Neurochem., 96, 706 718.
59. Sriram, K., Matheson, J.M., Benkovic, S.A., Miller, D.B., Luster, M.I. O'Callaghan, J.P. (2006b) Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. FASEB J., 20, 670 682.
60. Stellwagen, D. Malenka, R.C. (2006) Synaptic scaling mediated by glial TNF-alpha. Nature, 440, 1054 1059.
61. Streit, W.J., Walter, S.A. Pennell, N.A. (1999) Reactive microgliosis. Prog. Neurobiol., 57, 563 581.
62. Takasusuki, T., Fujiwara, T., Yamaguchi, S., Fukushima, T., Akagawa, K. Hori, Y. (2007) Enhancement of synaptic transmission and nociceptive behaviour in HPC-1/syntaxin 1A knockout mice following peripheral nerve injury. Eur. J. Neurosci., 26, 2179 2187.
63. Tan, X.L., Zhai, Y., Gao, W.X., Fan, Y.M., Liu, F.Y., Huang, Q.Y. Gao, Y.Q. (2009) p300 expression is induced by oxygen deficiency and protects neurons cells from damage. Brain Res., 1254, 1 9.
64. Tartaglia, L.A., Rothe, M., Hu, Y.F. Goeddel, D.V. (1993) Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell, 73, 213 216.
65. Thomas, D.M. Kuhn, D.M. (2005a) MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Res., 1050, 190 198.
66. Thomas, D.M. Kuhn, D.M. (2005b) Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced neurotoxicity. J. Pharmacol. Exp. Ther., 313, 870 876.
67. Thompson, P.M., Hayashi, K.M., Simon, S.L., Geaga, J.A., Hong, M.S., Sui, Y., Lee, J.Y., Toga, A.W., Ling, W. London, E.D. (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci., 24, 6028 6036.
68. Tsuji, T., Asanuma, M., Miyazaki, I., Miyoshi, K. Ogawa, N. (2008) Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen. Neurochem. Res., 34, 764 774.
69. Tuttolomondo, A., Di Raimondo, D., di Sciacca, R., Pinto, A. Licata, G. (2008) Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des., 14, 3574 3589.
70. Wallace, T.L., Vorhees, C.V., Zemlan, F.P. Gudelsky, G.A. (2003) Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain. Neuroscience, 116, 1063 1068.
71. Xie, T., Tong, L., Barrett, T., Yuan, J., Hatzidimitriou, G., McCann, U.D., Becker, K.G., Donovan, D.M. Ricaurte, G.A. (2002) Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity. J. Neurosci., 22, 274 283.
72. Yamaguchi, T., Kuraishi, Y., Minami, M., Nakai, S., Hirai, Y. Satoh, M. (1991) Methamphetamine-induced expression of interleukin-1 beta mRNA in the rat hypothalamus. Neurosci. Lett., 128, 90 92.
73. Zhang, X., Dong, F., Mayer, G.E., Bruch, D.C., Ren, J. Culver, B. (2007) Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats. Neuroscience, 150, 950 958.
74. Zhu, M.Y., Wang, W.P., Huang, J. Regunathan, S. (2007) Chronic treatment with glucocorticoids alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levels. J. Neurochem., 103, 1811 1820.